Skip to Main Content

Rise and shine, everyone, the middle of the week is here, and you should be congratulated for making it this far — and we encourage you to continue. After all, consider the alternatives. Not so pleasant, yes? So time to reach for a cup of stimulation — and another cup of optimism — and push onward. That is what we did last night on the PBS NewsHour, in you case missed it. Meanwhile, we have assembled the usual tidbits. Have a great day and do keep in touch …

Mylan Pharmaceuticals is in the process of cutting nearly 10 percent of its 35,000-person global workforce, a spokeswoman confirms. She noted that the cuts have already been underway and pointed to recent acquisitions as one explanation, but refused to provide details. The drug maker is struggling in the face of pricing pressures for its generics business and mired in controversy over pricing of its EpiPen device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!